European Penny Stocks Under €80M Market Cap To Consider

The European market has recently experienced a pullback, with the pan-European STOXX Europe 600 Index ending 1.24% lower amid concerns about overvaluation in artificial intelligence-related stocks. Despite these challenges, the search for promising investment opportunities continues, particularly among smaller companies that might not be on every investor's radar. While the term "penny stocks" may seem outdated, these smaller or newer companies can still offer significant growth potential when supported by strong financials. In this article, we'll explore several penny stocks that stand out for their financial strength and potential to provide value to investors seeking hidden gems in the market.

Top 10 Penny Stocks In Europe

Click here to see the full list of 279 stocks from our European Penny Stocks screener.

We'll examine a selection from our screener results.

Patria Bank (BVB:PBK)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Patria Bank SA is a credit institution offering banking and financial services to individuals, small and medium enterprises, agribusinesses, and corporate customers in Romania, with a market cap of RON370.51 million.

Operations: The company's revenue is primarily derived from its banking operations, totaling RON240.37 million.

Market Cap: RON370.51M

Patria Bank SA, with a market cap of RON370.51 million, has demonstrated strong financial performance recently. The bank's net income for the first half of 2025 was RON24.26 million, up from RON18.47 million the previous year, reflecting a robust earnings growth of 41.6% over the past year—surpassing industry averages significantly. Despite having a low return on equity at 10.4%, its price-to-earnings ratio is attractive at 8x compared to the broader market average of 14.8x, suggesting potential undervaluation for investors interested in penny stocks with stable profitability and moderate asset management practices.

• Click to explore a detailed breakdown of our findings in Patria Bank's financial health report.
• Gain insights into Patria Bank's outlook and expected performance with our report on the company's earnings estimates.

High (ENXTPA:HCO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: High Co. SA offers consumer engagement chain solutions in France, Belgium, and Spain with a market cap of €77.07 million.

Operations: The company generates revenue from its advertising segment, amounting to €143.31 million.

Market Cap: €77.07M

High Co. SA, with a market cap of €77.07 million, has seen a decline in earnings and profit margins recently, reporting net income of €4.46 million for the first half of 2025 compared to €6.37 million the previous year. Despite this, the company trades at 75.3% below its estimated fair value and maintains strong financial health with cash exceeding total debt and interest payments well covered by EBIT (29.1x). However, its share price remains highly volatile and earnings growth has been negative over the past year, posing risks for investors seeking stability in penny stocks.

• Unlock comprehensive insights into our analysis of High stock in this financial health report.
• Learn about High's future growth trajectory here.

Nexam Chemical Holding (OM:NEXAM)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Nexam Chemical Holding AB (publ) develops solutions to improve the properties and performance of plastics across Sweden, Europe, and internationally, with a market cap of SEK258.12 million.

Operations: The company's revenue is derived from two segments: Performance Chemicals, contributing SEK86.73 million, and Performance Masterbatch, accounting for SEK110.99 million.

Market Cap: SEK258.12M

Nexam Chemical Holding AB, with a market cap of SEK258.12 million, is trading significantly below its estimated fair value and has maintained a satisfactory net debt to equity ratio of 8.9%. Despite being unprofitable, the company reported revenue growth to SEK46.5 million in Q3 2025 from SEK44.09 million a year prior but also saw increased net losses over the same period. Recent advancements in bioplastic technology could enhance its product offerings and sustainability profile, presenting potential growth opportunities. Nexam's experienced management and board provide stability, with short-term assets covering both short- and long-term liabilities comfortably.

• Jump into the full analysis health report here for a deeper understanding of Nexam Chemical Holding.
• Gain insights into Nexam Chemical Holding's future direction by reviewing our growth report.

Seize The Opportunity

• Investigate our full lineup of 279 European Penny Stocks right here.
• Seeking Other Investments? The end of cancer? These 29 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com